Theriva Biologics (TOVX) Preferred Shares (2018 - 2020)
Theriva Biologics (TOVX) posted quarterly Preferred Shares of $2.5 million for Q4 2020, down 47.97% year-over-year from $4.8 million in Q1 2020, and down 4.14% quarter-over-quarter from $2.6 million in Q3 2020.
Theriva Biologics (TOVX) Preferred Shares (2018 - 2020) Analysis & Trends
Theriva Biologics (TOVX) has reported Preferred Shares for 3 consecutive years, with $2.5 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Preferred Shares fell 47.97% year-over-year to $2.5 million; the TTM figure through Dec 2020 stood at $2.5 million (down 47.97% YoY), while the FY2020 annual figure was $2.5 million, down 47.97% from the prior year.
- Preferred Shares fell to $2.5 million in Q4 2020 per TOVX's latest filing, from $2.6 million in the prior quarter.
- Across five years, Preferred Shares topped out at $5.8 million in Q4 2018 and bottomed at $2.5 million in Q4 2020.
- Historically, Preferred Shares has averaged $4.2 million across 3 years, with a median of $4.8 million in 2019.
- Annual changes were most pronounced in 2019 — Preferred Shares dropped 17.34% — and 2020, when it plunged 47.97%.
- Theriva Biologics' Preferred Shares stood at $5.8 million in 2018, then dropped by 17.34% to $4.8 million in 2019, then slumped by 47.97% to $2.5 million in 2020.
- Business Quant data shows TOVX's Preferred Shares at $2.5 million in Q4 2020, $2.6 million in Q3 2020, and $3.4 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.48 Mn |
| Sep 30, 2020 | 2.58 Mn |
| Jun 30, 2020 | 3.44 Mn |
| Mar 31, 2020 | 4.09 Mn |
| Dec 31, 2019 | 4.76 Mn |
| Sep 30, 2019 | 4.82 Mn |
| Jun 30, 2019 | 4.94 Mn |
| Mar 31, 2019 | 5.12 Mn |
| Dec 31, 2018 | 5.76 Mn |